{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:32:48Z","timestamp":1793136768024,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74352-x","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:06:04Z","timestamp":1781273164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineering human PEG10-based nanoparticles for RNA self-packaging, delivery and cancer therapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Pin-Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Lun","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy Anh","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quyen Thuc","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuong Thi Kieu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9997-4467","authenticated-orcid":false,"given":"Yu-Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"74352_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-024-00943-2","volume":"23","author":"JR Androsavich","year":"2024","unstructured":"Androsavich, J. R. Frameworks for transformational breakthroughs in RNA-based medicines. Nat. Rev. Drug Discov. 23, 421\u2013444 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74352_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","volume":"23","author":"K Paunovska","year":"2022","unstructured":"Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23, 265\u2013280 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"74352_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","volume":"23","author":"D Bitounis","year":"2024","unstructured":"Bitounis, D., Jacquinet, E., Rogers, M. A. & Amiji, M. M. Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nat. Rev. Drug Discov. 23, 281\u2013300 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74352_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","volume":"23","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. mRNA-based cancer therapeutics. Nat. Rev. Cancer 23, 526\u2013543 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"74352_CR5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s41565-021-00928-x","volume":"16","author":"N Dammes","year":"2021","unstructured":"Dammes, N. et al. Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics. Nat. Nanotechnol. 16, 1030\u20131038 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"74352_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"74352_CR7","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Blood\u2013brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nat. Mater. 24, 1653\u20131663 (2025).","journal-title":"Nat. Mater."},{"key":"74352_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41586-025-09873-4","volume":"650","author":"MJ Friedrich","year":"2026","unstructured":"Friedrich, M. J. et al. Transient hepatic reconstitution of trophic factors enhances aged immunity. Nature 650, 481\u2013489 (2026).","journal-title":"Nature"},{"key":"74352_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","volume":"21","author":"L Cheng","year":"2022","unstructured":"Cheng, L. & Hill, A. F. Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discov. 21, 379\u2013399 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74352_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jconrel.2023.03.009","volume":"356","author":"L Nieland","year":"2023","unstructured":"Nieland, L., Mahjoum, S., Grandell, E., Breyne, K. & Breakefield, X. O. Engineered EVs designed to target diseases of the CNS. J. Control Release 356, 493\u2013506 (2023).","journal-title":"J. Control Release"},{"key":"74352_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","volume":"21","author":"K O\u2019Brien","year":"2020","unstructured":"O\u2019Brien, K., Breyne, K., Ughetto, S., Laurent, L. C. & Breakefield, X. O. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat. Rev. Mol. Cell Biol. 21, 585\u2013606 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"74352_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot, P. E. et al. Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat. Commun. 10, 45 (2019).","journal-title":"Nat. Commun."},{"key":"74352_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265 (2022).","journal-title":"Cell"},{"key":"74352_CR14","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","volume":"42","author":"M An","year":"2024","unstructured":"An, M. et al. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat. Biotechnol. 42, 1526\u20131537 (2024).","journal-title":"Nat. Biotechnol."},{"key":"74352_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-02085-z","author":"JR Hamilton","year":"2024","unstructured":"Hamilton, J. R. et al. In vivo human T cell engineering with enveloped delivery vehicles. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-023-02085-z (2024).","journal-title":"Nat. Biotechnol."},{"key":"74352_CR16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1126\/science.abg6155","volume":"373","author":"M Segel","year":"2021","unstructured":"Segel, M. et al. Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science 373, 882\u2013889 (2021).","journal-title":"Science"},{"key":"74352_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41392-021-00803-0","volume":"6","author":"K Riecken","year":"2021","unstructured":"Riecken, K., G\u0142\u00f3w, D. & Fehse, B. How to package and SEND mRNA: a novel \u201chumanized\u201d vector system based on endogenous retroviruses. Sig. Transduc. Target. Ther. 6, 384 (2021).","journal-title":"Sig. Transduc. Target. Ther."},{"key":"74352_CR18","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41587-021-01124-x","volume":"39","author":"A Gutkin","year":"2021","unstructured":"Gutkin, A., Rosenblum, D. & Peer, D. RNA delivery with a human virus-like particle. Nat. Biotechnol 39, 1514\u20131515 (2021).","journal-title":"Nat. Biotechnol"},{"key":"74352_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1586\/14760584.2014.951637","volume":"13","author":"S-Y Lin","year":"2014","unstructured":"Lin, S.-Y., Chung, Y.-C. & Hu, Y.-C. Update on baculovirus as an expression and\/or delivery vehicle for vaccine antigens. Expert Rev. Vaccines 13, 1501\u20131521 (2014).","journal-title":"Expert Rev. Vaccines"},{"key":"74352_CR20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","volume":"15","author":"MD Shin","year":"2020","unstructured":"Shin, M. D. et al. COVID-19 vaccine development and a potential nanomaterial path forward. Nat. Nanotechnol 15, 646\u2013655 (2020).","journal-title":"Nat. Nanotechnol"},{"key":"74352_CR21","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/nprot.2014.130","volume":"9","author":"L-Y Sung","year":"2014","unstructured":"Sung, L.-Y. et al. Efficient gene delivery into cell lines and stem cells using baculovirus. Nat. Protoc. 9, 1882\u20131899 (2014).","journal-title":"Nat. Protoc."},{"key":"74352_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122106","volume":"297","author":"NTK Nguyen","year":"2023","unstructured":"Nguyen, N. T. K. et al. Split dCas12a activator for lncRNA H19 activation to enhance BMSC differentiation and promote calvarial bone healing. Biomaterials 297, 122106 (2023).","journal-title":"Biomaterials"},{"key":"74352_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120965","volume":"275","author":"NTK Nguyen","year":"2021","unstructured":"Nguyen, N. T. K. et al. CRISPR activation of long non-coding RNA DANCR promotes bone regeneration. Biomaterials 275, 120965 (2021).","journal-title":"Biomaterials"},{"key":"74352_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtice.2025.106304","volume":"176","author":"S-W Yang","year":"2025","unstructured":"Yang, S.-W. et al. Neuropathic pain attenuation by adipose-derived stem cells engineered with RNA-guided gene activation. J. Taiwan Inst. Chem. Eng. 176, 106304 (2025).","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"74352_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52707-6","volume":"15","author":"VA Truong","year":"2024","unstructured":"Truong, V. A. et al. Programmable editing of primary microRNA switches stem cell differentiation and improves tissue regeneration. Nat. Commun. 15, 8358 (2024).","journal-title":"Nat. Commun."},{"key":"74352_CR26","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.1093\/nar\/gkac587","volume":"50","author":"F Aulicino","year":"2022","unstructured":"Aulicino, F. et al. Highly efficient CRISPR-mediated large DNA docking and multiplexed prime editing using a single baculovirus. Nucleic Acids Res. 50, 7783\u20137799 (2022).","journal-title":"Nucleic Acids Res."},{"key":"74352_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkag121","volume":"54","author":"QT Dang","year":"2026","unstructured":"Dang, Q. T. et al. CRISPR-associated transposon for programmable viral vector engineering and prime editing. Nucleic Acids Res. 54, gkag121 (2026).","journal-title":"Nucleic Acids Res."},{"key":"74352_CR28","doi-asserted-by":"publisher","unstructured":"Caracausi, M. et al. Systematic identification of human housekeeping genes possibly useful as references in gene expression studies. Mol. Med. Rep. 16, https:\/\/doi.org\/10.3892\/mmr.2017.6944 (2017).","DOI":"10.3892\/mmr.2017.6944"},{"key":"74352_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2017.06.005","volume":"67","author":"A Gentilella","year":"2017","unstructured":"Gentilella, A. et al. Autogenous control of 5\u2032TOP mRNA stability by 40S ribosomes. Mol. Cell 67, 55\u201370 (2017).","journal-title":"Mol. Cell"},{"key":"74352_CR30","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s42003-022-03941-5","volume":"5","author":"M Inoue","year":"2022","unstructured":"Inoue, M. et al. Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS\/ERK pathway. Commun. Biol. 5, 974 (2022).","journal-title":"Commun. Biol."},{"key":"74352_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.devcel.2020.11.007","volume":"55","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Programmable extracellular vesicles for macromolecule delivery and genome modifications. Dev. Cell 55, 784\u2013801 (2020).","journal-title":"Dev. Cell"},{"key":"74352_CR32","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1002\/jex2.40","volume":"1","author":"ER Dellar","year":"2022","unstructured":"Dellar, E. R., Hill, C., Melling, G. E., Carter, D. R. F. & Baena-Lopez, L. A. Unpacking extracellular vesicles: RNA cargo loading and function. J. Extracell. Biol. 1, e40 (2022).","journal-title":"J. Extracell. Biol."},{"key":"74352_CR33","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.ymthe.2024.02.025","volume":"32","author":"M Muskan","year":"2024","unstructured":"Muskan, M. et al. Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles. Mol. Ther. 32, 2939\u20132949 (2024).","journal-title":"Mol. Ther."},{"key":"74352_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/mt.2012.286","volume":"21","author":"KJ Airenne","year":"2013","unstructured":"Airenne, K. J. et al. Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol. Ther. 21, 739\u2013749 (2013).","journal-title":"Mol. Ther."},{"key":"74352_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06945-7","volume":"15","author":"N Li","year":"2024","unstructured":"Li, N. et al. PD-L1 induces autophagy and primary resistance to EGFR\u2013TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell Death Dis. 15, 555 (2024).","journal-title":"Cell Death Dis."},{"key":"74352_CR36","doi-asserted-by":"publisher","first-page":"32840","DOI":"10.1021\/acsomega.2c03517","volume":"7","author":"S Rehman","year":"2022","unstructured":"Rehman, S. et al. Emerging biomedical applications of the vesicular stomatitis virus glycoprotein. ACS Omega 7, 32840\u201332848 (2022).","journal-title":"ACS Omega"},{"key":"74352_CR37","first-page":"E28","volume":"114","author":"IS Kim","year":"2017","unstructured":"Kim, I. S. et al. Mechanism of membrane fusion induced by vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. USA 114, E28\u2013E36 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74352_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn8579","volume":"10","author":"L Milojevi\u0107","year":"2024","unstructured":"Milojevi\u0107, L. et al. Capturing intermediates and membrane remodeling in class III viral fusion. Sci. Adv. 10, eadn8579 (2024).","journal-title":"Sci. Adv."},{"key":"74352_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc7804","volume":"13","author":"C Hotz","year":"2021","unstructured":"Hotz, C. et al. Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models. Sci. Transl. Med. 13, eabc7804 (2021).","journal-title":"Sci. Transl. Med."},{"key":"74352_CR40","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s43018-020-0095-6","volume":"1","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity. Nat. Cancer 1, 882\u2013893 (2020).","journal-title":"Nat. Cancer"},{"key":"74352_CR41","doi-asserted-by":"publisher","first-page":"eaat9143","DOI":"10.1126\/scitranslmed.aat9143","volume":"11","author":"SL Hewitt","year":"2019","unstructured":"Hewitt, S. L. et al. Durable anticancer immunity from intratumoral administration of IL-23, IL-36g and OX40L mRNAs. Sci. Transl. Med. 11, eaat9143 (2019).","journal-title":"Sci. Transl. Med."},{"key":"74352_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2017.12.024","volume":"172","author":"ED Pastuzyn","year":"2018","unstructured":"Pastuzyn, E. D. et al. The neuronal gene Arc encodes a repurposed retrotransposon Gag protein that mediates intercellular RNA transfer. Cell 172, 275\u2013288 (2018).","journal-title":"Cell"},{"key":"74352_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41551-023-01150-x","volume":"8","author":"W Gu","year":"2024","unstructured":"Gu, W. et al. Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons. Nat. Biomed. Eng. 8, 415\u2013426 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"74352_CR44","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cell.2017.12.022","volume":"172","author":"J Ashley","year":"2018","unstructured":"Ashley, J. et al. Retrovirus-like Gag protein Arc1 binds RNA and traffics across synaptic boutons. Cell 172, 262\u2013274.e211 (2018).","journal-title":"Cell"},{"key":"74352_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307812120","volume":"121","author":"V Madigan","year":"2024","unstructured":"Madigan, V. et al. Human paraneoplastic antigen Ma2 (PNMA2) forms icosahedral capsids that can be engineered for mRNA delivery. Proc. Natl. Acad. Sci. USA 121, e2307812120 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74352_CR46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015960","volume":"296","author":"AM Whiteley","year":"2021","unstructured":"Whiteley, A. M. et al. Global proteomics of Ubqln2-based murine models of ALS. J. Biol. Chem. 296, 100153 (2021).","journal-title":"J. Biol. Chem."},{"key":"74352_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100360","volume":"2","author":"NJ Pandya","year":"2021","unstructured":"Pandya, N. J. et al. Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology. Cell Rep. Med. 2, 100360 (2021).","journal-title":"Cell Rep. Med."},{"key":"74352_CR48","doi-asserted-by":"publisher","unstructured":"Campodonico, W. et al. The gag-like gene RTL8 antagonizes PEG10-mediated virus like particles. PLoS ONE 19, https:\/\/doi.org\/10.1371\/journal.pone.0310946 (2024).","DOI":"10.1371\/journal.pone.0310946"},{"key":"74352_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.98579.3","volume":"13","author":"R Tang","year":"2024","unstructured":"Tang, R. et al. Engineering PEG10 assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccination. Elife 13, RP98579 (2024).","journal-title":"Elife"},{"key":"74352_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi8075","volume":"8","author":"DS Jones","year":"2022","unstructured":"Jones, D. S. et al. Cell surface\u2013tethered IL-12 repolarizes the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy. Sci. Adv. 8, eabi8075 (2022).","journal-title":"Sci. Adv."},{"key":"74352_CR51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.coi.2010.02.013","volume":"22","author":"JM Curtsinger","year":"2010","unstructured":"Curtsinger, J. M. & Mescher, M. F. Inflammatory cytokines as a third signal for T cell activation. Curr. Opin. Immunol. 22, 333\u2013340 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"74352_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-025-01509-2","author":"JP Murad","year":"2025","unstructured":"Murad, J. P. et al. Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery. Nat. Biomed. Eng. https:\/\/doi.org\/10.1038\/s41551-025-01509-2 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"74352_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41423-025-01261-2","volume":"22","author":"I Ogulur","year":"2025","unstructured":"Ogulur, I. et al. Type 2 immunity in allergic diseases. Cell. Mol. Immunol. 22, 211\u2013242 (2025).","journal-title":"Cell. Mol. Immunol."},{"key":"74352_CR54","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"MG Alameh","year":"2021","unstructured":"Alameh, M. G. et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity 54, 2877\u20132892 (2021).","journal-title":"Immunity"},{"key":"74352_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303261","volume":"35","author":"Y Zong","year":"2023","unstructured":"Zong, Y., Lin, Y., Wei, T. & Cheng, Q. Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy. Adv. Mater. 35, e2303261 (2023).","journal-title":"Adv. Mater."},{"key":"74352_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"74352_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33157-4","volume":"13","author":"S Li","year":"2022","unstructured":"Li, S. et al. Payload distribution and capacity of mRNA lipid nanoparticles. Nat. Commun. 13, 5561 (2022).","journal-title":"Nat. Commun."},{"key":"74352_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114535","volume":"190","author":"N Yom-Tov","year":"2022","unstructured":"Yom-Tov, N., Guy, R. & Offen, D. Extracellular vesicles over adeno-associated viruses: Advantages and limitations as drug delivery platforms in precision medicine. Adv. Drug Deliv. Rev. 190, 114535 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"74352_CR59","doi-asserted-by":"publisher","unstructured":"Park, J. E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 367, https:\/\/doi.org\/10.1126\/science.aay3224 (2020).","DOI":"10.1126\/science.aay3224"},{"key":"74352_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ng1699","volume":"38","author":"R Ono","year":"2006","unstructured":"Ono, R. et al. Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality. Nat. Genet. 38, 101\u2013106 (2006).","journal-title":"Nat. Genet."},{"key":"74352_CR61","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3892\/or.2014.3469","volume":"32","author":"X Deng","year":"2014","unstructured":"Deng, X. et al. PEG10 plays a crucial role in human lung cancer proliferation, progression, prognosis and metastasis. Oncol. Rep. 32, 2159\u20132167 (2014).","journal-title":"Oncol. Rep."},{"key":"74352_CR62","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.celrep.2015.07.012","volume":"12","author":"S Akamatsu","year":"2015","unstructured":"Akamatsu, S. et al. The placental gene PEG10 promotes progression of neuroendocrine prostate cancer. Cell Rep. 12, 922\u2013936 (2015).","journal-title":"Cell Rep."},{"key":"74352_CR63","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2009.22","volume":"4","author":"RH Kutner","year":"2009","unstructured":"Kutner, R. H., Zhang, X. Y. & Reiser, J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 4, 495\u2013505 (2009).","journal-title":"Nat. Protoc."},{"key":"74352_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ymthe.2021.08.024","volume":"30","author":"VA Truong","year":"2022","unstructured":"Truong, V. A. et al. Bi-directional gene activation and repression promote ASC differentiation and enhance bone healing in osteoporotic rats. Mol. Ther. 30, 92\u2013104 (2022).","journal-title":"Mol. Ther."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74352-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:10:50Z","timestamp":1785517850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74352-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74352"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74352-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7479"}}